In contrast to its potent effects in the PUS7‐overexpressing setting, DNase I treatment did not significantly alter tumour volume (Figure S13A,B) or macrophage polarization status (Figure S13C–F) in Vector control tumours, nor did it cause significant body weight loss (Figure S13G). The gene discussed is PUS7; the disease is neoplasm.